Raoul Orvieto1,2, David B Seifer3. 1. Department of Obstetrics and Gynecology, Infertility and IVF Unit, Chaim Sheba Medical Center (Tel Hashomer), Ramat Gan, 52621, Israel. raoul.orvieto@sheba.health.gov.il. 2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. raoul.orvieto@sheba.health.gov.il. 3. Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
The original version of this article [1] unfortunately contained an error.The following lines regarding RCT [23] in Table 1: ‘…the Gonal-f group achieved non significantly more oocytes of (10.7 vs 10.6, respectively), despite lower peak E2 levels and lower cancellation rate (7704 vs 8982 pmol/L and 0.8 % vs 2.0 %, respectively) with…’ has been corrected.This has been corrected to: ‘...the Gonal-f group achieved non significantly less oocytes (10.4 vs 10.7, respectively), with lower peak E2 levels and lower cancellation rate (7704 vs 8982 pmol/L and 8.9 % vs 11.2 %, respectively) with the consequent decreased incidence of OHSS…".